tradingkey.logo

Tandem Diabetes Care Inc

TNDM
View Detailed Chart
14.000USD
-0.820-5.53%
Close 10/10, 16:00ETQuotes delayed by 15 min
945.43MMarket Cap
LossP/E TTM

Tandem Diabetes Care Inc

14.000
-0.820-5.53%
Intraday
1m
30m
1h
D
W
M
D

Today

-5.53%

5 Days

+6.79%

1 Month

+11.46%

6 Months

-20.50%

Year to Date

-61.13%

1 Year

-64.21%

View Detailed Chart

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. The company is performing strongly in the stock market, with strong fundamentals and technicals supporting the momentum. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Tandem Diabetes Care Inc's Score

Industry at a Glance

Industry Ranking
54 / 205
Overall Ranking
143 / 4699
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 23 analysts
Hold
Current Rating
20.667
Target Price
+34.72%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Tandem Diabetes Care Inc Highlights

StrengthsRisks
Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 17.35% year-on-year.
Overvalued
The company’s latest PE is -4.81, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 81.67M shares, decreasing 9.25% quarter-over-quarter.
Held by PRFDX
Star Investor PRFDX holds 19.68K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.67.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Tandem Diabetes Care Inc Info

Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.
Ticker SymbolTNDM
CompanyTandem Diabetes Care Inc
CEOMr. John F. Sheridan
Websitehttps://www.tandemdiabetes.com/
KeyAI